Clinical Trials Browser

Phase 2 × INDUSTRY × Sturge-Weber Syndrome × Clear all

NCT04947124 2025-01-20

A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101

Phase 2 Completed

Glaucoma, Hydrophthalmos, Ocular Hypertension, Sturge-Weber Syndrome

NCT05495269 2025-01-20

Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)

Phase 2 Completed

Glaucoma, Ocular Hypertension, Sturge-Weber Syndrome